Medical News Today: Relapsing-remitting MS: Alemtuzumab boosts outcomes for black patients

A trial reveals that the drug alemtuzumab may improve outcomes for black patients with relapsing-remitting multiple sclerosis, who are often understudied. Medical News Today: Relapsing-remitting MS: Alemtuzumab boosts outcomes for black patients